GLP-1 and Weight Management
As demand for GLP-1 medications continues to grow, employers face important questions about long-term effectiveness, rising costs, and sustainable weight management outcomes. This white paper examines employee behaviors, prescribing patterns, and treatment expectations to uncover where current approaches may fall short. You'll learn why obesity requires more than medication alone, how integrated care teams improve support, and what employees say they need to succeed. Through survey findings, clinical insights, and real-world outcomes from Levanto's Healthy Weight program, the paper outlines four practical strategies for building a more effective obesity care benefit.